Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt–Koyanagi–Harada disease
Marie‐Hélène Errera(University of Pittsburgh), Phuc LeHoang(Sorbonne Université), Audrey Navarro(Assistance Publique – Hôpitaux de Paris), David Cohen(Assistance Publique – Hôpitaux de Paris), Alain Gaudric(Université Paris Cité), Christine Fardeau(Sorbonne Université), Bahram Bodaghi(Sorbonne Université), Mark Westcott(Barts Health NHS Trust)
Cited by 47
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
|Lara D. Veeken|2007|301
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207